Extensive in vitro and in vivo analyses demonstrated that PTf‐SRiApt preferentially suppresses the proliferation of “transcriptionally addicted” TNBC cancer cells with heightened SCAF4 and POLR2A expression. Here, POLR2A is linked to cancer.